Foghorn Therapeutics Inc. Common Stock (NASDAQ: FHTX) last traded at $2.00, up 0.50% on the session. The quote above updates while this page is open; the figures below are drawn from Foghorn Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Foghorn Therapeutics Inc. Common Stock trades on NASDAQ under the ticker FHTX. Its market capitalisation is $118.77 million.
Valuation measures for Foghorn Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $118.77M |
|---|---|
| Enterprise value | $335.12M |
| Price / sales | 3.23 |
| Beta | 1.59 |
Trailing-twelve-month figures tagged in Foghorn Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $36.74M |
| Net income (TTM) | -$64.58M |
|---|
| EPS (TTM) | -$0.990 |
|---|
| Operating margin | -198.04% |
|---|
| Cash | $68.08M |
|---|
Range and volume for FHTX over the past 52 weeks.
| 52-week high | $7.61 |
|---|---|
| 52-week low | $1.79 |
| Volume | 647.0K |
| Average volume | 629.9K |
| Previous close | $1.99 |
Invest a chosen dollar amount in Foghorn Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell FHTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.